Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
Advanced urothelial carcinoma (UC) is a very important cause of cancer-related morbidity and mortality with, until recently, only a few available therapeutic options. The treatment landscape has dramatically changed in recent years with the introduction of immune checkpoint inhibitors and the develo...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020-01-01
|
| Col·lecció: | Cancer Treatment and Research Communications |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2468294220300162 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|